Last reviewed · How we verify

NCT06327737

Diabetic Ketoacidosis Diagnosis and Management

Completed Last updated 25 March 2024
What this trial tests

trial testing Capnography in Metabolic Acidosis in 55 participants. Completed in 15 March 2023.

Timeline
15 December 2020
Primary endpoint
15 November 2022
15 March 2023

Quick facts

Lead sponsorAkdeniz University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment55
Start date15 December 2020
Primary completion15 November 2022
Estimated completion15 March 2023
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Akdeniz University

Who can join

Adults 15 Days to 18, any sex, with Metabolic Acidosis or Diabetic Ketoacidosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is the first and only study conducted on the use of capnography in children diagnosed with DKA to evaluate the initial clinical grading of DKA, monitor clinical improvement, and predict complications such as brain edema.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. The contribution of end-tidal carbon dioxide monitoring to the management of pediatric patients with diabetic ketoacidosis.
    Kendir OT, Kahraman C, Tekerek NU, Gurlu R, et al · · 2026 · PMID 41033061 · DOI 10.1016/j.ajem.2025.09.050

Verify or expand the search:

Other trials of Capnography

Trials testing the same drug.

Other recruiting trials for Metabolic Acidosis

Currently open trials in the same condition.

Other Akdeniz University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06327737.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing